Cardiorenal risk in type 2 diabetes: a case-based discussion
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Through the lens of a hypothetical patient, Jenny, let's look beyond glucose management in people with type 2 diabetes and address their cardiorenal risk.
AstraZeneca medicines will be mentioned during this presentation.
GB-58815, DOP: Sept 2024